Separation, Identification, and Characterization of Degradation Products of Erlotinib Hydrochloride Under ICH-Recommended Stress Conditions by LC, LC-MS/TOF

References

• Dowell , J. ; Minna , J. D. ; Kirkpatrick , P. Fresh from the Pipeline Erlotinib Hydrochloride . Nature Reviews Drug Discovery 2005 , 4 , 13 – 14 .
   PubMed Web of Science ®Google Scholar
• Padmalatha , M. ; Kulsum , S. ; Rahul , C. ; Reddy , D. T. ; Vidyasagar , G. Spectrophotometric Methods for the Determination of Erlotinib in Pure and Pharmaceutical Dosage Forms . Int. J. Pharm. Res. Dev. 2011 , 3 ( 6 ), 103 – 109 .
   Google Scholar
• Padmalatha , H. ; Vidyasagar , G. Development and Validation of UV Spectrophotometric Method for the Determination of Erlotinib in Tablet Formulation . Imperial J. Med. Org. Chem. 2011 , 1 ( 1 ), 26 – 30 .
   Google Scholar
• Mandal , B. ; Balabathula , P. ; Mittal , N. ; Wood , G. C. ; Bhattacharjee , H. Development and Validation of a Spectrofluorimetric Method for the Determination of Erlotinib in Spiked Human Plasma . J. Fluoresc. 2012 , 22 , 1425 – 1429 .
   PubMed Web of Science ®Google Scholar
• Rajesh , V. ; Anupama , B. ; Jagathi , V. ; Varaprasad , K. High Performance Thin Layer Chromatographic Method for Estimation of Erlotinib Hydrochloride as Bulk Drug . Int. J. Biol. Med. Res. 2011 , 2 ( 1 ), 433 – 435 .
   Google Scholar
• Ding , X. ; Zhang , C. ; Xu , Z. ; Zhang , Q. ; Wu , H. ; Ma , Z. W. J. Determination of Erlotinib in Rabbit Plasma by Liquid Chromatography Mass Spectrometry . Lat. Am. J. Pharm. 2012 , 31 ( 4 ), 501 – 506 .
   Web of Science ®Google Scholar
• Pan , J. ; Jiang , X. ; Yu-Luan , C. Automatic Supported Liquid Extraction (SLE) Coupled with HILIC-MS/MS: An Application to Method Development and Validation of Erlotinib in Human Plasma . Pharmaceutics 2010 , 2 ( 2 ), 105 – 118 .
   PubMedGoogle Scholar
• Lepper , E. R. ; Swain , S. M. ; Tan , A. R. ; Figg , W. D. ; Sparreboom , A. Liquid-Chromatographic Determination of Erlotinib (OSI-774), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor . J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003 , 796 ( 1 ), 181 – 188 .
   PubMed Web of Science ®Google Scholar
• Zhao , M. ; He , P. ; Rudek , M. A. ; Hidalgo , M. ; Baker , S. D. Specific Method for Determination of OSI-774 and Its Metabolite OSI-420 in Human Plasma by Using Chromatography-Tandem Mass Spectrometry . J. Chromatogr. B 2003 , 793 ( 2 ), 413 – 420 .
   PubMed Web of Science ®Google Scholar
• Honeywell , R. ; Yarzadah , K. ; Giovannetti , E. ; Losekoot , N. ; Smit , E. F. ; Walraven , M. ; Lind , J. S. W. ; Tibaldi , C. ; Verheul , H. M. ; Peters , G. J. Simple and Selective Method for the Determination of Various Tyrosine Kinase Inhibitors Used in the Clinical Setting by Liquid Chromatography Tandem Mass Spectrometry . J. Chromatogr. B 2010 , 878 ( 15–16 ), 1059 – 1068 .
   PubMed Web of Science ®Google Scholar
• Signor , L. ; Varsesio , E. ; Staack , R. F. ; Starke , V. ; Richter , W. F. ; Hopfgartner , G. Analysis of Erlotinib and Its Metabolites in Rat Tissue Sections by MALDI Quadrupole Time-of-Flight Mass Spectrometry . J. Mass. Spect. 2007 , 42 ( 7 ), 900 – 909 .
   PubMed Web of Science ®Google Scholar
• Karunakara , C. ; Udupi , A. ; Chandregowda , V. ; Reddy , V. C. G. Separation and Determination of Process-Related Impurities of Erlotinib Using Reverse-Phase HPLC with a Photo-Diode Detector . Anal. Sci. 2012 , 28 , 305 – 308 .
   PubMed Web of Science ®Google Scholar
• Pujeri , S. S. ; Khader , A. M. A. ; Seetharamappa , J. Validated Stability-Indicating Chromatographic Method for the Assay of Erlotinib Active Pharmaceutical Ingredient . Anal. Lett. 2009 , 42 , 1855 – 1867 .
   Web of Science ®Google Scholar
• Bouchet , S. ; Chauzit , E. ; Ducint , D. ; Castaing , N. ; Canal-Raffin , M. ; Moore , N. Simultaneous Determination of Nine Tyrosine Kinase Inhibitors by 96-Well Solid-Phase Extraction and Ultra Performance LC/MS-MS . Clin. Chim. Acta 2011 , 412 ( 11–12 ), 1060 – 1067 .
   PubMed Web of Science ®Google Scholar
• Chakravarthy , V. K. ; Shankar , D. G. Development and Validation of RP-HPLC Method for Estimation of Erlotinib in Bulk and Its Pharmaceutical Formulation . Rasayan J. Chem. 2011 , 4 ( 2 ), 393 – 399 .
   Google Scholar
• Conaway , M. C. P. ; Bui , H. ; Beachy , S. ; Pitoniak , R. ; Hylander , B. ; Wang , P. ; Marlar , K. ; Repasky , E. ; Kazim , L. Determining Distribution of Erlotinib in Pancreatic Tumors by MALDI Using an LTQ Linear Ion Trap, LCGC North Am. The Application Notebook – June 2008 Advertising Supplement 58 , 2008 .
   Google Scholar
• Couchman , L. ; Birch , M. ; Ireland , R. ; Corrigan , A. ; Wickramasinghe , S. ; Josephs , D. ; Spicer , J. ; Flanagan , R. J. An Automated Method for the Measurement of a Range of Tyrosine Kinase Inhibitors in Human Plasma or Serum Using Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry . Anal. Bioanal. Chem. 2012 , 403 , 1685 – 1695 .
   PubMed Web of Science ®Google Scholar
• Dziadosz , M. ; Lessig , R. ; Bartels , H. HPLC-DAD Protein Kinase Inhibitor Analysis in Human Serum . J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012 , 893–894 , 77 – 81 .
   PubMed Web of Science ®Google Scholar
• Faivre , L. ; Gomo , C. , Mir , O. ; Taieb , F. ; Schoemann-Thomas , A. ; Ropert , S. ; Vidal , M. ; Dusser , D. ; Dauphin , A. ; Goldwasser , F. , Blanchet , B. A Simple HPLC-UV Method for the Simultaneous Quantification of Gefitinib and Erlotinib in Human Plasma . J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2011 , 879 ( 23 ), 2345 – 2350 .
   PubMed Web of Science ®Google Scholar
• Gomez-Canela , C. ; Cortes-Francisco , N. ; Ventura , F. ; Caixach , J. ; Lacorte , S. Liquid Chromatography Coupled to Tandem Mass Spectrometry and High Resolution Mass Spectrometry as Analytical Tools to Characterize Multiclass Cytostatic . J. Chromatogr. A 2013 , 1276 , 78 – 94 .
   PubMed Web of Science ®Google Scholar
• Konda , R. K. ; Babu , K. S. ; Nagabhushanam , C. H. A validated LC Method for the Estimation of Erlotinib in Bulk and Tablet Dosage Form . Int. J. Pharm. Biomed. Res. 2013 , 4 ( 1 ), 1 – 4 .
   PubMedGoogle Scholar
• Lankheet , N. A. ; Hilebrand , M. J. ; Rosing , H. ; Schellens , J. H. ; Beijnen , J. H. ; Huitema , A. D. Method Development and Validation for the Quantification of Dasatinib, Erlotinib, Gefitinib, Imatinib, Lapatinib, Nilotinib, Sorafenib and Sunitinib in Human Plasma by Liquid Chromatography Coupled with Mass Spectrometry . Biomed. Chromatogr. 2013 , 27 ( 4 ), 466 – 476 .
   PubMed Web of Science ®Google Scholar
• Lankheet , N. A. ; Schaake , E. E. ; Rosing , H. ; Burgers , J. A. ; Schellens , J. H. ; Beijnen , J. H. ; Huitema , A. D. Quantitative Estimation of Erlotinib and O-Desmethyl Erlotinib in Human EDTA Plasma and Lung Tumor Tissue . Bioanalysis 2012 , 4 ( 21 ), 2563 – 2577 .
   PubMed Web of Science ®Google Scholar
• Li , H-Q. ; Chen , Y. ; Li , Z-Q. ; Deng , C-H. ; Li , L. ; Bi , S.-S. ; Li , M.-Y. ; Zhou , T.-Y. ; Lu , W. A High Performance Liquid Chromatography Method for the Quantitative Determination of Erlotinib in the Plasma of Tumor Bearing BALB/C Nude Mice and Its Application in a Pharmacokinetic Study . J. Chin. Pharm. Sci. 2011 , 20 ( 3 ), 245 – 252 .
   Google Scholar
• Negreira , N. ; Lopez , de Alda M. ; Barcelo , D. Online Solid Phase Extraction-Liquid Chromatography Tandem Mass Spectrometry for the Determination of 17 Cytostatics and Metabolites in Waste, Surface and Ground Water Samples . J. Chromatogr. A 2013 , 1280 , 64 – 74 .
   PubMed Web of Science ®Google Scholar
• Padmalatha , M. ; Prakash , K. V. ; Kusum , S. , Kumar1 , R. V. ; Wilson1 , K. ; Vivekananda1 , V. Development and Validation of High Performance Liquid Chromatographic Method for the Determination of Erlotinib. J. Pharm. Res. 2011, 4 (3), 637–638.
   Google Scholar
• Reddy , G. N. K. ; Prasad , V. V. S. R. ; Maharana , P. K. Development and Validation of a Stability Indicating UPLC Method for Determination of Erlotinib in Pharmaceutical Formulations . Pharma. Chem. 2012 , 4 ( 6 ), 2288 – 2297 .
   Google Scholar
• Saravanan , V. S. ; Rao , B. M. Analytical Method Development and Validation for the Determination of Erlotinib Hydrochloride Bulk and in Pharmaceutical Dosage Form . J. Drug Delivery. Ther. 2013 , 3 ( 1 ), 50 – 54 .
   Google Scholar
• Signor , L. ; Varesio , E. ; Staack , R. ; Starke , D. ; Richter , W. ; Hopfgartner , G. Analysis of Erlotinib and Its Metabolites in Rat Tissue Sections by MALDI Quadrupole Time-of-Flight Mass Spectrometry . J. Mass Spectrom. 2007 , 42 ( 7 ), 900 – 909 .
   PubMed Web of Science ®Google Scholar
• Streit , F. ; Binder , L. ; Hafke , A. ; Brandhorst , G. ; Braulke , F. ; Haase , D. ; Armbrust , T. ; Cameron , S. ; Ramadori , G. ; Oellerich , M. ; Walson , P. Use of Total and Unbound Imatinib and Metabolite LC-MS/MS Assay to Understand Individual Responses in CML and GIST Patients . Ther. Drug Monit. 2011 , 33 ( 5 ), 632 – 643 .
   PubMed Web of Science ®Google Scholar
• Thappali , S. R. S. ; Varanasi , K. ; Veeraraghavan , S. ; Arla , R. ; Chennupati , S. ; Rajamanickam , M. ; Vakkalanka , S. ; Khagga , M. Simultaneous Determination of Celecoxib, Erlotinib, and Its Metabolite Desmethyl Erlotinib (OSI-420) in Rat Plasma by Liquid Chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation . Sci. Pharm. 2012 , 80 ( 3 ), 633 – 646 .
   PubMedGoogle Scholar
• Zhang , W. ; Siu , L. L. ; Moore , M. J. ; Chen , E. X. Simultaneous Determination of OSI-774 and Its major Metabolite OSI-420 in Human Plasma by Using HPLC with UV Detection . J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2005 , 814 ( 1 ), 143 – 147 .
   PubMed Web of Science ®Google Scholar
• Zhen , Y. ; Thomas-Schoemann , A. ; Sakji , L. ; Boudou-Rouquette , P. ; Dupin , N. ; Mortier , L. ; Vidal , M. ; Goldwasser , F. ; Blanchet , B. An HPLC-UV Method for the Simultaneous Quantification of Vemurafenib and Erlotinib in Plasma from Cancer Patients . J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2013 , 928 , 93 – 97 .
   PubMed Web of Science ®Google Scholar
• Andriamanana , I. ; Gana , I. ; Duretz , B. ; Hulin , A. Simultaneous Analysis of Anticancer Agents Bortezomib, Imatanib, Nilotinib, Dasatinib, Erlotinib, Lapatinib, Sorafenib, Sunitinib and Vandetanib in Human Plasma Using LC/MS/MS . J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2013 , 926 , 83 – 91 .
   PubMed Web of Science ®Google Scholar
• Masters , A. R. ; Sweeney , C. J. ; Jones , D. R. The Quantification of Erlotinib (OSI-774) and OSI-420 in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry . J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007 , 848 ( 2 ), 379 – 383 .
   PubMed Web of Science ®Google Scholar
• I.C.H. Stability Testing of New Drug Substances and Products Q1A(R2), in: International Conference on Harmonization, IFMPA, Geneva , 2003 .
   Google Scholar
• Mahajan , A. A. ; Thaker , A. K. ; Mohanraj , K. LC, LC-MS/MS Studies for the Identification and Characterization of Degradation Products of Hydrochlorothiazide and Establishment of Mechanistic Approach Towards Degradation . J. Braz. Chem. Soc. 2012 , 23 ( 3 ), 445 – 452 .
   Web of Science ®Google Scholar
• Mahajan , A. A. ; Thaker , A. K. ; Kale , S. ; Mohanraj , K. 2012 LC, LC-MS/MS Studies for Identification and Characterization of Degradation Products of Lamotrigine and Establishment of Mechanistic Approach Towards Degradation . J. Liq. Chromatogr. Relat. Technol. 2012 , 35 ( 16 ), 2255 – 2271 .
   Web of Science ®Google Scholar
• Mahajan , A. A. ; Thaker , A. K. ; Kale , S. ; Mohanraj , K. Study of Olopatadine Hydrochloride Under ICH Recommended Stress Conditions by LC-MS/TOF for Identification and Characterization of Degradation Products . J. Liq. Chromatogr. Relat. Technol. 2013 , 36 ( 13 ), 1881 – 1898 .
   Web of Science ®Google Scholar
• I.C.H. Validation of Analytical Procedures: Text and Methodology, Q2 (R1), International Conference on Harmonization IFPMA, Geneva, 2005 .
   Google Scholar